---
title: "Sipai Health Technology to Divest Subsidiary Group to Dashenlin for RMB51.73 Million"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/283692362.md"
description: "Sipai Health Technology Co., Ltd. has agreed to divest 100% of a wholly owned subsidiary and two additional subsidiaries to Dashenlin for RMB51.73 million. This transaction, which is subject to consideration adjustments, will streamline Sipai's operations and financial reporting. The deal is classified as a discloseable transaction under Hong Kong Listing Rules, requiring notification but not a shareholder vote. Sipai will provide further details in a subsequent announcement, noting that the transaction is conditional and may not proceed."
datetime: "2026-04-22T15:10:25.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/283692362.md)
  - [en](https://longbridge.com/en/news/283692362.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/283692362.md)
---

# Sipai Health Technology to Divest Subsidiary Group to Dashenlin for RMB51.73 Million

### Claim 30% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

An update from Sipai Health Technology Co., Ltd. ( (HK:0314) ) is now available.

Sipai Health Technology has agreed to sell 100% of the equity in a wholly owned subsidiary, together with the equity of two additional subsidiaries to be injected into that entity before closing, to Dashenlin for RMB51.73 million, subject to a consideration adjustment. Upon completion, the disposed company and its subsidiaries will cease to be part of Sipai’s consolidated group, while Dashenlin will obtain full control of these assets, marking a portfolio realignment that could streamline Sipai’s operations and financial reporting under Hong Kong listing rules.

The deal qualifies as a discloseable transaction under Hong Kong Listing Rules, triggering notification and announcement requirements but not a shareholder vote. As the valuation of the target group involves an income-based assessment of intangible assets and is treated as a profit forecast under local regulations, Sipai plans a further announcement with additional required information, while cautioning investors that the transaction remains conditional and may not ultimately proceed.

**More about Sipai Health Technology Co., Ltd.**

Sipai Health Technology Co., Ltd. is a Cayman Islands-incorporated company listed in Hong Kong, operating in the healthcare and health technology sector. Through its subsidiaries, it provides medical-related services and solutions, and manages a portfolio of healthcare assets that it actively optimizes via acquisitions and disposals to refine its business focus and capital allocation.

**Average Trading Volume:** 1,131,803

**Technical Sentiment Signal:** Sell

**Current Market Cap:** HK$1.11B

Learn more about 0314 stock on TipRanks’ Stock Analysis page.

### Related Stocks

- [00314.HK](https://longbridge.com/en/quote/00314.HK.md)
- [603233.CN](https://longbridge.com/en/quote/603233.CN.md)

## Related News & Research

- [The Trading Awards: Voting is open until 19 May](https://longbridge.com/en/news/286793607.md)
- [Triumph New Energy Sets 2025 AGM to Approve Profit Plan, Auditor and Board Changes](https://longbridge.com/en/news/287049811.md)
- [Wide postpones 2026 annual meeting to June 17; proxy voting deadline June 16](https://longbridge.com/en/news/286911986.md)
- [ARTRARI ONE CAPITAL CORP. REPORTS ON VOTING RESULTS FROM THE 2026 ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS](https://longbridge.com/en/news/286606232.md)
- [ELFI offers new private student loan alternative for medical and healthcare students facing federal loan changes](https://longbridge.com/en/news/286929682.md)